Encompass Health Corporation (EHC) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Encompass Health Corporation (EHC) Healthcare & Pipeline Overview

Encompass Health Corporation, a major player in the U.S. post-acute healthcare market, delivers facility-based and home-based services through its Inpatient Rehabilitation and Home Health & Hospice segments. With a wide geographic reach and focus on specialized rehabilitative care, EHC addresses the growing demand for post-acute services.

What Is the Investment Thesis for EHC?

The company's diversified service offerings, spanning inpatient rehabilitation and home health & hospice, cater to a broad range of patient needs. With a market capitalization of $12.0B and a P/E ratio of 16.46, EHC demonstrates financial stability and profitability, supported by a 10.0% profit margin and a 58.8% gross margin. Growth catalysts include the increasing demand for post-acute care driven by an aging population and advancements in medical treatments. The company's strategic expansion of its facility network and home health locations further supports revenue growth. Potential risks include regulatory changes in healthcare reimbursement and increased competition from other post-acute care providers.

Based on FMP financials and quantitative analysis

EHC Key Highlights

Market capitalization of $12.0B, reflecting substantial investor confidence in the company's market position and future growth prospects.

• P/E ratio of 16.46, indicating a reasonable valuation relative to earnings, suggesting potential for further appreciation.
• Profit margin of 10.0%, demonstrating efficient operations and effective cost management within the healthcare sector.
• Gross margin of 58.8%, highlighting the company's ability to generate significant revenue from its services, exceeding industry averages.
• Dividend yield of 0.70%, providing a steady income stream for investors, enhancing the overall investment appeal.

Who Are EHC's Competitors?

EHC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are EHC's Key Strengths?

Leading market position in the post-acute care industry.

• Diversified service offerings across inpatient rehabilitation, home health, and hospice.
• Extensive geographic footprint with a large network of facilities.
• Strong brand reputation and relationships with payers.

What Are EHC's Weaknesses?

Exposure to regulatory changes and reimbursement pressures.

• Labor shortages and rising labor costs in the healthcare industry.
• Dependence on government funding and potential changes in healthcare policy.
• Geographic concentration in certain regions, limiting growth opportunities.

What Could Drive EHC Stock Higher?

Continued expansion of inpatient rehabilitation facilities to meet growing demand.

• Strategic acquisitions of home health and hospice agencies to increase market share.
• Implementation of new telehealth and remote monitoring technologies to improve patient outcomes (expected Q4 2026).
• Focus on value-based care initiatives to enhance reimbursement rates and attract more patients.
• Demographic shifts with an aging population driving increased demand for post-acute care services.

What Are the Key Risks for EHC?

Insider selling — insiders were net sellers of roughly $29.3M recently.

• Regulatory changes and reimbursement pressures impacting revenue and profitability.
• Labor shortages and rising labor costs in the healthcare industry affecting operational efficiency.
• Increased competition from other post-acute care providers eroding market share.
• Cyberattacks and data breaches compromising patient information and disrupting operations.
• Economic downturn potentially reducing patient volumes and impacting revenue.

What Are the Growth Opportunities for EHC?

• Expansion of Inpatient Rehabilitation Facilities: Encompass Health can capitalize on the growing demand for inpatient rehabilitation services by strategically expanding its network of facilities. The market for inpatient rehabilitation is projected to reach $40 billion by 2028, driven by an aging population and increasing prevalence of chronic conditions. By adding new facilities in underserved markets and enhancing existing facilities with advanced technologies, Encompass Health can increase its market share and revenue. This expansion can be achieved through acquisitions, joint ventures, or greenfield developments, with a focus on high-growth regions.
• Growth in Home Health and Hospice Services: The home health and hospice segment presents significant growth opportunities for Encompass Health. The market for home healthcare is expected to reach $300 billion by 2030, fueled by the increasing preference for home-based care and advancements in remote monitoring technologies. Encompass Health can expand its home health and hospice services by increasing its geographic coverage, enhancing its service offerings with specialized programs, and leveraging technology to improve patient outcomes and efficiency. Strategic acquisitions of smaller home health agencies can accelerate this growth.
• Leveraging Technology and Telehealth: Encompass Health can enhance its service delivery and improve patient outcomes by leveraging technology and telehealth solutions. The telehealth market is projected to reach $175 billion by 2026, driven by the increasing adoption of remote monitoring, virtual consultations, and digital therapeutics. Encompass Health can invest in telehealth platforms to provide remote rehabilitation services, monitor patients' progress, and offer virtual consultations. This will improve access to care, reduce costs, and enhance patient satisfaction. The integration of AI-powered tools can further personalize treatment plans and optimize resource allocation.
• Strategic Partnerships and Collaborations: Encompass Health can strengthen its market position and expand its service offerings by forming strategic partnerships and collaborations with other healthcare providers, payers, and technology companies. Collaborating with hospitals and physician groups can create referral networks and ensure a steady stream of patients. Partnering with payers can develop value-based care models and improve reimbursement rates. Collaborating with technology companies can integrate innovative solutions into its service delivery. These partnerships can enhance Encompass Health's competitive advantage and drive revenue growth.
• Focus on Value-Based Care: Encompass Health can capitalize on the shift towards value-based care by demonstrating its ability to deliver high-quality, cost-effective post-acute care. Value-based care models reward providers for achieving positive patient outcomes and reducing healthcare costs. Encompass Health can invest in data analytics and quality improvement initiatives to track patient outcomes, identify areas for improvement, and demonstrate its value to payers. By participating in value-based care programs, Encompass Health can increase its reimbursement rates and attract more patients.

What Are EHC's Competitive Advantages?

• Established brand reputation and market leadership in the post-acute care industry.
• Extensive network of hospitals, home health locations, and hospice locations across multiple states.
• Specialized expertise in providing comprehensive rehabilitation and home healthcare services.
• Strong relationships with payers, including Medicare, Medicaid, and commercial insurance companies.

What Does EHC Do?

Encompass Health Corporation, founded in 1983 and headquartered in Birmingham, Alabama, has evolved into a prominent provider of facility-based and home-based post-acute healthcare services across the United States. Originally known as HealthSouth Corporation, the company rebranded in January 2018 to reflect its expanded focus. Encompass Health operates through two primary segments: Inpatient Rehabilitation and Home Health & Hospice. The Inpatient Rehabilitation segment delivers specialized rehabilitative treatment to patients recovering from conditions such as stroke, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. These services are offered on both an inpatient and outpatient basis. The Home Health & Hospice segment provides a range of home health services, including skilled nursing, medical social work, and home health aide services, along with physical, occupational, and speech therapy, primarily in the Southeast and Texas. This segment also offers in-home hospice services to terminally ill patients and their families. As of June 1, 2022, Encompass Health operated 149 hospitals, 252 home health locations, and 99 hospice locations across 42 states and Puerto Rico, demonstrating its extensive national footprint and commitment to delivering comprehensive post-acute care.

What Products and Services Does EHC Offer?

• Operates inpatient rehabilitation facilities providing specialized treatment for patients recovering from serious injuries and illnesses.
• Offers home health services, including skilled nursing, therapy, and medical social work, in patients' homes.
• Provides hospice care for terminally ill patients and their families, focusing on comfort and support.
• Manages a network of hospitals, home health locations, and hospice locations across multiple states.
• Delivers rehabilitative treatment on an outpatient basis.
• Offers specialized programs for conditions such as stroke, neurological disorders, and orthopedic injuries.
• Coordinates care with physicians, hospitals, and other healthcare providers to ensure seamless transitions for patients.

How Does EHC Make Money?

• Generates revenue through facility-based inpatient and outpatient rehabilitation services.
• Earns revenue from home health services, including skilled nursing and therapy.
• Receives payments for hospice care services provided to terminally ill patients.
• Contracts with Medicare, Medicaid, commercial insurance companies, and private payers for reimbursement.

What Industry Does EHC Operate In?

Encompass Health operates within the expanding post-acute care industry, driven by an aging population and increasing prevalence of chronic diseases. The market is characterized by a growing demand for rehabilitation and home healthcare services. The competitive landscape includes national and regional providers, as well as smaller, independent operators. Encompass Health's scale, geographic reach, and comprehensive service offerings position it as a leading player in this fragmented market. Competitors include ENSG: The Ensign Group, Inc., which also operates in the skilled nursing and rehabilitation space.

Who Are EHC's Key Customers?

• Patients recovering from stroke, neurological disorders, cardiac conditions, and other serious illnesses or injuries.
• Individuals requiring skilled nursing, therapy, or other healthcare services in their homes.
• Terminally ill patients and their families seeking hospice care and support.
• Hospitals and physician groups that refer patients to Encompass Health for post-acute care.

Over the past six months, Encompass Health Corporation insiders filed 44 SEC Form 4 transactions — 11 sales and 33 purchases. On net that is roughly 223K shares disposed (about $29.3M), a signal worth weighing alongside the fundamentals.

Encompass Health Corporation has beaten Wall Street's EPS estimate in 8 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 9.6% above estimates on average.

Encompass Health Corporation's Piotroski F-Score is 8/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 3.48 places it in the safe zone, indicating low near-term bankruptcy risk.

Return on equity for Encompass Health Corporation stands at 25.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 8.3%, showing how much profit it generates from its asset base. EHC trades at a trailing price-to-earnings ratio of 16.46, below the Healthcare sector average of ~21.50x. Its free cash flow yield is 4.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.17 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 6.1%, the inverse of the P/E and a quick read on earnings relative to price.

Encompass Health Corporation (EHC) Valuation Context

Valued at $12.0B, EHC is classified as a large-cap stock. Analyst price targets span from $144.00 to $155.00, with a consensus of $150.25. At the current price of $121.04, that implies approximately 24% upside potential. Relative to its peer group, EHC's quantitative score of 89/100 is above the peer average of 79/100.

EHC Revenue & Earnings Trend

In Q2 FY2026, EHC generated $1.60B in top-line revenue, marking a sequential increase of 0.7%. The company recorded net income of $153.9M, with diluted EPS of $1.54. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this large-cap Healthcare company. Across the four most recent quarters, EHC averaged $1.54 in diluted EPS.

Company Profile

Encompass Health Corporation operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Birmingham, US. The company is led by CEO Mark J. Tarr. EHC has traded publicly since 1986.

EHC Financials

EHC Latest News

EHC Analyst Consensus

EHC MoonshotScore

Common Questions About EHC (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources